Compare NTRA & QSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NTRA | QSR |
|---|---|---|
| Founded | 2003 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.0B | 24.9B |
| IPO Year | 2015 | 2006 |
| Metric | NTRA | QSR |
|---|---|---|
| Price | $243.30 | $68.08 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 17 |
| Target Price | ★ $249.53 | $74.44 |
| AVG Volume (30 Days) | 1.1M | ★ 2.4M |
| Earning Date | 02-26-2026 | 02-11-2026 |
| Dividend Yield | N/A | ★ 3.65% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.81 |
| Revenue | $2,116,676,000.00 | ★ $9,264,000,000.00 |
| Revenue This Year | $33.42 | $12.60 |
| Revenue Next Year | $16.96 | $3.96 |
| P/E Ratio | ★ N/A | $24.25 |
| Revenue Growth | ★ 38.17 | 16.82 |
| 52 Week Low | $125.38 | $58.71 |
| 52 Week High | $256.36 | $73.70 |
| Indicator | NTRA | QSR |
|---|---|---|
| Relative Strength Index (RSI) | 57.62 | 45.91 |
| Support Level | $226.66 | $67.45 |
| Resistance Level | $243.69 | $69.91 |
| Average True Range (ATR) | 9.63 | 1.24 |
| MACD | -0.30 | -0.01 |
| Stochastic Oscillator | 56.41 | 47.74 |
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
Restaurant Brands generates about $44 billion in system sales across more than 32,000 restaurants in over 120 markets, making it one of the largest restaurant companies globally. Its banners include Burger King (7,082 stores), Tim Hortons (4,539), Popeyes (3,520), and Firehouse Subs (1,345), concentrated in the US and Canada, with these brands also comprising 15,639 franchised international locations as of year-end 2024. The firm primarily earns revenue from franchise and property fees, supply chain sales within the Tim Hortons segment, company-operated restaurants, and advertising royalties.